Updates on immunotherapy trials in HPV-HNSCC
Thursday, June 16, 2016
Head and Neck Session
•
HN 04
•
4:15 PM
>
5:45 PM
•
Updates on immunotherapy trials in HPV-HNSCC
•
Wolf Dietrich
Head and Neck Session
•
HN 04-01
•
Pembrolizumab in Head and Neck Cancer: Phase 1 Trial Results
See abstract
>
F.
Fan
Jin
•
HN 04-02
•
Intratumoral IL12 gene electro-transfer therapy for HNSCC
See abstract
>
R.
Robert
Pierce
•
HN 04-03
•
Strategies to Improve Response Rates in Recurrent and/or Metastatic Head and Neck Cancer Patients Who Have Progressed on Anti-PD-1, Anti-PD-L1, or Anti-CTLA-4 Monotherapy
See abstract
>
S.
Sara
Pai
•
HN 04-04
•
Immune biomarkers in recurrent Head and Neck squamous cell carcinoma
See abstract
>
D.
Dan
Clayburgh
•
HN 04-05
•
Immune biomarkers in the primary and metastatic site
>
M.
Mihir
Patel
|